Determination of fluoxetine and norfluoxetine concentrations in cadaveric allograft skin.

Abstract:

:Fluoxetine hydrochloride is the sixth most prescribed drug in the United States and is administered to treat major depression. A cadaveric skin donation was obtained from a 46-year-old woman who died as a result of a fluoxetine overdose. Due to the potential penetration of the drug and its major metabolite, norfluoxetine, into skin, the safety of using the skin as an allograft was questioned. Our evaluation showed that mean concentrations in skin were 2304+/-175 and 1353+/-102 ng/g of skin, respectively. The skin:plasma ratio was 0.41. Clinically, the amount of fluoxetine that can be transferred to an allograft recipient depends on many factors. Based on penetration of drug and metabolite into skin, one would have to evaluate carefully the risk:benefit ratio of using allografts from a donor who died from a fluoxetine overdose.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Neudeck BL,Taddonio TE,Garner WL,Welage LS

subject

Has Abstract

pub_date

1998-07-01 00:00:00

pages

851-5

issue

4

eissn

0277-0008

issn

1875-9114

journal_volume

18

pub_type

杂志文章
  • Piperacillin-Tazobactam: a new beta-lactam-beta-lactamase inhibitor combination.

    abstract::We reviewed the spectrum of activity, pharmacokinetics, clinical efficacy, adverse effects, and relative advantages of piperacillin-tazobactam, a new beta-lactam-beta-lactamase inhibitor. Piperacillin-tazobactam has a wide spectrum of activity that includes gram-positive organisms such as staphylococci and streptococc...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Daniel KP,Krop LC

    更新日期:1996-03-01 00:00:00

  • Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillation.

    abstract::Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with thromboembolic events and hemodynamic impairment that results in considerable morbidity, mortality, and cost. Cardioversion to sinus rhythm is a common approach to the treatment of these patients. However, cardioversion is assoc...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.23.1.57.31917

    authors: Wodlinger AM,Pieper JA

    更新日期:2003-01-01 00:00:00

  • Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination.

    abstract::A 26-year-old woman developed significant unilateral anterior cervical and supraclavicular lymphadenopathy 3 days after receiving her first dose (of a total of three doses) of human papilloma virus (HPV) vaccine. She had no history of lymphadenopathy after other previous immunizations, and had received no vaccines oth...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.9.1194

    authors: Studdiford J,Lamb K,Horvath K,Altshuler M,Stonehouse A

    更新日期:2008-09-01 00:00:00

  • Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.

    abstract:BACKGROUND:Modification of guideline-directed medical therapy (GDMT) in hospitalized patients with heart failure (HF) has not been extensively evaluated. METHODS:The community surveillance arm of the Atherosclerosis Risk in Communities Study identified 6959 HF hospitalizations from 2005-2011. Predictors of GDMT modifi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1002/phar.2091

    authors: Tran RH,Aldemerdash A,Chang P,Sueta CA,Kaufman B,Asafu-Adjei J,Vardeny O,Daubert E,Alburikan KA,Kucharska-Newton AM,Stearns SC,Rodgers JE

    更新日期:2018-04-01 00:00:00

  • Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis.

    abstract::We conducted a systematic review of randomized, controlled, monotherapy trials since 1990 of oral antihypertensive agents in patients with essential hypertension. Our objective was to quantify the frequency of discontinuation of antihypertensive agents due to adverse events from a meta-analysis of the studies. A total...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,meta分析

    doi:10.1592/phco.21.11.940.34520

    authors: Ross SD,Akhras KS,Zhang S,Rozinsky M,Nalysnyk L

    更新日期:2001-08-01 00:00:00

  • National evaluation of prescriber drug dispensing.

    abstract:OBJECTIVE:To describe the legal, professional, and consumer status of prescribers dispensing legend and over-the-counter drugs in the United States. METHODS:Legal and academic databases were searched to identify those states that permit prescribers to dispense medications to patients and any limitations on such practi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1461

    authors: Munger MA,Ruble JH,Nelson SD,Ranker L,Petty RC,Silverstein S,Barton E,Feehan M

    更新日期:2014-10-01 00:00:00

  • A pharmacoeconomic model to evaluate antibiotic costs.

    abstract:STUDY OBJECTIVES:To characterize patient sociodemographics and health, describe vancomycin treatment parameters and clinician-rated outcomes, and determine costs associated with treatment including preparation and administration, adverse events, and toxicity. DESIGN:A prospective study to develop a model for costs ass...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Garrelts JC,Horst WD,Silkey B,Gagnon S

    更新日期:1994-07-01 00:00:00

  • Effect of hepatic disease on the pharmacokinetics and plasma protein binding of eprosartan.

    abstract:STUDY OBJECTIVE:To evaluate the pharmacokinetics and plasma protein binding of eprosartan in hepatic disease. DESIGN:Single-dose, parallel-group study. SETTING:Oklahoma Foundation for Digestive Research, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. PATIENTS:Eight healthy subjects with norm...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Tenero D,Martin D,Chapelsky M,Ilson B,Boike S,Patterson S,Keogh J,Rodriguez S,Jorkasky D

    更新日期:1998-01-01 00:00:00

  • Preparing clinical pharmacy scientists for careers in clinical/translational research: can we meet the challenge?: ACCP Research Affairs Committee Commentary.

    abstract::Developing clinical pharmacists' research skills and their ability to compete for extramural funding is an important component of the American College of Clinical Pharmacy's (ACCP) vision for pharmacists to play a prominent role in generating the new knowledge used to guide patient pharmacotherapy. Given the recent em...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1348

    authors: Parker RB,Ellingrod V,DiPiro JT,Bauman JL,Blouin RA,Welage LS

    更新日期:2013-12-01 00:00:00

  • Bradycardia associated with intravenous administration of tacrolimus in a liver transplant recipient.

    abstract::Cardiotoxicity due to tacrolimus is documented infrequently in the medical literature. Sinus bradycardia associated with intravenous tacrolimus occurred in a 15-year-old orthotopic liver transplant recipient. The mechanism of this adverse effect is unknown; however, it does not appear to be concentration dependent, an...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Cox TH,Baillie GM,Baliga P

    更新日期:1997-11-01 00:00:00

  • Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?

    abstract::The era of the integrase strand transfer inhibitors (INSTIs) for the treatment of human immunodeficiency virus (HIV) infection began with raltegravir in 2007. Since that time, several other INSTIs have been introduced including elvitegravir, dolutegravir, and, most recently, bictegravir, that have shown great utility ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2246

    authors: Brooks KM,Sherman EM,Egelund EF,Brotherton A,Durham S,Badowski ME,Cluck DB

    更新日期:2019-05-01 00:00:00

  • Adverse reactions associated with systemic polymyxin therapy.

    abstract::The systemic polymyxins, colistin and polymyxin B, are increasingly used for multidrug-resistant bacterial infections and have a long history of dose-limiting toxicity. This review summarizes the most recent available information about the mechanisms, incidence, risk factors, and minimization strategies for polymyxin ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1493

    authors: Justo JA,Bosso JA

    更新日期:2015-01-01 00:00:00

  • Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literature.

    abstract::A 12-year-old girl with cystic fibrosis was diagnosed with a high-grade glioma after radiographic and biopsy results confirmed the primary intracranial lesion. She was treated with single-agent erlotinib during and after daily localized radiation therapy. Pharmacokinetic studies were conducted to assess the effect of ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.29.7.858

    authors: Christiansen SR,Broniscer A,Panetta JC,Stewart CF

    更新日期:2009-07-01 00:00:00

  • Lidocaine does not affect myocardial electrical heterogeneity: implications for low proarrhythmic actions.

    abstract::An area of unidirectional conduction block is one requirement for reentrant arrhythmias to occur. Functional block caused by dispersion of repolarization and refractoriness is the most probable mechanism of drug-induced unidirectional conduction block. We assessed the effects of lidocaine on spatial dispersion of myoc...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Sims JJ,Winecoff AP,Ujhelyi MR

    更新日期:1997-11-01 00:00:00

  • Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulations.

    abstract:STUDY OBJECTIVE:To evaluate the toxicity of amphotericin B deoxycholate formulations. DESIGN:In vitro experiment. SETTING:University research center. MATERIAL:Human mononuclear THP-1 cells. INTERVENTION:The human mononuclear cells were exposed in vitro for 2 hours to the following deoxycholate formulations of ampho...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.5.572.32209

    authors: Cleary JD,Rogers PD,Chapman SW

    更新日期:2003-05-01 00:00:00

  • The effect of theophylline on respiratory muscle contractility and fatigue.

    abstract::The traditional role of theophylline as a bronchodilator has been expanded by recent findings that suggest this drug has more than smooth muscle relaxant properties. Several investigators indicate that theophylline has an inotropic effect on respiratory muscle, causing enhanced muscular contraction and prevention of m...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Landsberg KF,Vaughan LM,Heffner JE

    更新日期:1990-01-01 00:00:00

  • Practical issues in the treatment of patients with heart failure.

    abstract::The management of heart failure is complex. Initiating and maintaining drug therapy in patients with heart failure can be challenging. Many factors influence the heart failure syndrome and are important to account for when evaluating these patients. Concomitant diseases such as ischemic heart disease and hypertension ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.20.18.385s.34609

    authors: Gattis WA

    更新日期:2000-11-01 00:00:00

  • Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.

    abstract::Atorvastatin calcium is an HMG-coenzyme A (CoA) reductase inhibitor that was approved by the Food and Drug Administration on December 17, 1996. Like other such agents, it inhibits the action of HMG-CoA reductase and thereby decreases endogenous cholesterol synthesis, leading to a decrease in circulating low-density li...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Chong PH,Seeger JD

    更新日期:1997-11-01 00:00:00

  • Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?

    abstract::Albuterol is a 50:50 mixture of R-albuterol, the active enantiomer, and S-albuterol, which appears to be inactive in humans. The Food and Drug Administration recently approved levalbuterol, the pure R-isomer, as a preservative-free nebulizer solution. Published studies indicate that it is neither safer nor more effect...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.20.3.123.34776

    authors: Asmus MJ,Hendeles L

    更新日期:2000-02-01 00:00:00

  • Graves' Disease Pharmacotherapy in Women of Reproductive Age.

    abstract::Graves' disease is an autoimmune disorder in which inappropriate stimulation of the thyroid gland results in unregulated secretion of thyroid hormones resulting in hyperthyroidism. Graves' disease is the most common cause of autoimmune hyperthyroidism during pregnancy. Treatment options for Graves' disease include thi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1676

    authors: Prunty JJ,Heise CD,Chaffin DG

    更新日期:2016-01-01 00:00:00

  • Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.

    abstract:STUDY OBJECTIVES:To evaluate the occurrence of bleeding and venous thromboembolic (VTE) events in patients receiving rivaroxaban, warfarin, or warfarin with the addition of enoxaparin during the immediate postoperative period following major orthopedic surgery. METHODS:Patients older than 18 years who received at leas...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1888

    authors: Cieri NE,Kusmierski K,Lackie C,Van Opdorp A,Hassan AK

    更新日期:2017-02-01 00:00:00

  • Hepatic drug metabolism in critical illness.

    abstract::Hepatic drug metabolism is altered in critically ill patients. The etiology and mechanisms of the alterations are not clearly understood and are difficult to address in clinical studies. For this reason, in vitro and animal models were developed to investigate the effects of critical illness on hepatic drug metabolism...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: McKindley DS,Hanes S,Boucher BA

    更新日期:1998-07-01 00:00:00

  • The use of intravenous nitroglycerin in cardiovascular disease.

    abstract::The development of an intravenous form of nitroglycerin has further enhanced the role of nitrates in the therapy of cardiovascular disorders. This new preparation permits prompt initiation of therapy and rapid attainment of high systemic levels; because of its short half-life, rapid dose titration is both feasible and...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.1982.tb03197.x

    authors: Jaffe AS,Roberts R

    更新日期:1982-09-01 00:00:00

  • Colistin: understanding and applying recent pharmacokinetic advances.

    abstract::Colistin, the most widely used polymyxin antibiotic, was originally introduced in the late 1950s before the establishment of the present-day drug approval process. Originally shelved due to toxicity concerns, colistin, in the form of its inactive prodrug colistin methanesulfonate, has undergone a renaissance in the pa...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1484

    authors: Ortwine JK,Kaye KS,Li J,Pogue JM

    更新日期:2015-01-01 00:00:00

  • Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.

    abstract:STUDY OBJECTIVE:To determine whether early administration of adjuvant β-lactam in combination with vancomycin (COMBO) affects clinical outcomes compared to standard vancomycin therapy alone (STAN) among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection. DESIGN:Retrospective, multic...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1002/phar.2034

    authors: Casapao AM,Jacobs DM,Bowers DR,Beyda ND,Dilworth TJ,REACH-ID Study Group.

    更新日期:2017-11-01 00:00:00

  • Options for the management of mucosal candidiasis in patients with AIDS and HIV infection.

    abstract::Oropharyngeal candidiasis may be the first manifestation of human immunodeficiency viral (HIV) infection, and more than 90% of patients with the acquired immunodeficiency syndrome (AIDS) develop the disease. Although numerous antifungal agents are available, azoles, both topical (clotrimazole) and systemic (fluconazol...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.1.76.30509

    authors: Vazquez JA

    更新日期:1999-01-01 00:00:00

  • Fluconazole-induced agranulocytosis with eosinophilia.

    abstract::Fluconazole is a commonly prescribed antifungal agent with a favorable safety profile. A patient experienced agranulocytosis and eosinophilia associated with the drug. Similar bone marrow-suppressive effect due to the azoles is rarely described in the English-language literature. ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.5.484.35058

    authors: Wong-Beringer A,Shriner K

    更新日期:2000-04-01 00:00:00

  • Antimicrobial formulary management: a case study in a teaching hospital.

    abstract::The role of the formulary system for effective cost containment is becoming increasingly important. With antimicrobial agents taking up a large proportion of most pharmaceutical budgets, this group of agents is an obvious target for cost reduction. The responsible interchange of selected antimicrobial agents offers a ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Wright DB

    更新日期:1991-01-01 00:00:00

  • Alprazolam in bipolar-I depressions.

    abstract::In an open-label study of alprazolam in five bipolar-I depressed patients, three patients remitted completely, one failed to respond, and one responded transiently, based on the Hamilton Rating Scale and Beck Depression Inventory scores. Further studies of alprazolam as an antidepressant are warranted. ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.1984.tb03311.x

    authors: Rush AJ,Schlesser MA,Erman M,Fairchild C

    更新日期:1984-01-01 00:00:00

  • Trends in antimicrobial resistance among today's bacterial pathogens.

    abstract::Resistance of nosocomial and community-acquired pathogens to antimicrobial agents is a serious problem with significant clinical consequences. Microbiologic surveillance data, such as those provided by the National Nosocomial Infections Surveillance System, supply information on current nosocomial pathogens in the Uni...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Thornsberry C

    更新日期:1995-01-01 00:00:00